查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1476328

2030 年微生物脂肪酶市场预测：按来源、形式、纯度、功能、最终用户和地区进行的全球分析

Microbial Lipase Market Forecasts to 2030 - Global Analysis By Source (Bacteria, Fungi, Yeast and Other Sources), Form (Liquid, Powder, Granular and Other Forms), Purity, Functionality, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球微生物脂肪酶市场规模为 6.5727 亿美元，预计预测期内复合年增长率为 8.6%，到 ​​2030 年将达到 117098 万美元。

微生物脂肪酶是由细菌、真菌等微生物产生的酶，在脂质代谢中扮演至关重要的角色。催化三酸甘油酯中酯键的水解，将其分解为甘油和脂肪酸。它可以增强风味和质地，并有助于脂肪的消化。由于其在较宽的 pH 值和温度范围内的稳定性，它在工业过程中受到重视。

人们对基于酶的解决方案的认识不断增强

基于酵素的解决方案，尤其是微生物脂肪酶，为食品生产、生质燃料生产和製药等製程提供了永续且环保的替代方案。随着业界寻求更有效率、更环保的解决方案，对微生物脂肪酶的需求不断增加。其以高特异性和高效率催化特定反应的能力，加上酶工程和生产技术的进步，进一步巩固了其作为重要生物催化剂的地位，并正在推动市场扩张。

稳定性和保质期有限

微生物脂肪酶的稳定性和保质期有限是由于储存期间和不利条件下可能发生的酶变性、蛋白水解和聚集等因素造成的。这些限制阻碍了它们在各种工业应用中的有效性和适用性，并影响产品品质和性能。因此，工业界可能会减少对微生物脂肪酶的依赖，并寻求替代酶源或具有更长保质期和更高稳定性的合成替代品。

生物技术领域的拓展

微生物脂肪酶在生质燃料生产、药物合成和清洁剂製造等生物技术领域中发挥重要作用。随着生物技术的进步，由于微生物脂肪酶的多功能性、高效性和环境友善性，其需求预计将进一步增加。这一趋势正在推动微生物脂肪酶开发的创新，提高其性能并扩大应用范围，从而刺激生物技术领域的市场扩张。

技术挑战

微生物脂肪酶的技术挑战包括配方优化、製程条件微调和基材相容性。确保在各种工业条件下获得最佳的酵素稳定性和活性是很困难的。此外，在不影响品质的情况下实现具有成本效益的生产方法仍然是一个挑战。这些技术障碍阻碍了微生物脂肪酶的普及和应用，并影响了市场成长。

COVID-19 的影响

COVID-19 大流行对微生物脂肪酶市场产生了各种影响。对加工食品和清洁剂的需求增加增加了某些行业对微生物脂肪酶的需求，而供应链中断、劳动力短缺和经济不确定性给市场相关人员带来了挑战。此外，产业暂时关闭和消费者支出下降正在减缓市场成长。然而，市场正在表现出韧性，快速适应远距工作，日益关注卫生产品，并加速支持市场復苏和未来成长前景的生物技术研究。

预计细菌细分市场在预测期内将是最大的细分市场

推测该细菌片段具有良好的生长。微生物脂肪酶是一种由细菌产生的酶，在各种工业应用中发挥重要作用。这些脂肪酶源自不同的细菌菌株，在不同条件下表现出显着的基材特异性和稳定性，使其在生物技术、食品加工和医学中具有价值。脂肪酶催化脂质中酯键的水解，促进乳酪成熟、清洁剂配方和生物柴油生产等过程。

预计製药领域在预测期内复合年增长率最高

预计製药公司领域在预测期内复合年增长率最高。微生物脂肪酶是由细菌和真菌等微生物产生的酶，在製药公司中具有重要用途。脂肪酶在药物製剂中的作用是协助药物化合物的合成、促进药物吸收、提高药物稳定性。它对于生产对映体纯药物也至关重要，这可以确保疗效并最大限度地减少副作用。

比最大的地区

预计亚太地区在预测期内将占据最大的市场占有率。快速的工业化、不断扩大的食品和饮料行业以及对酵素产品不断增长的需求正在推动市场扩张。此外，可支配收入的增加以及对更健康、更方便食品的饮食偏好的改变正在推动该地区对微生物脂肪酶的需求。此外，政府积极支持生物技术研究和开发的措施也进一步推动了市场成长。

复合年增长率最高的地区：

预计北美在预测期内的复合年增长率最高。该地区先进的食品和饮料行业，加上对酶解决方案不断增长的需求，是一个关键的驱动力。此外，技术进步、积极的研发活动和支持性法规结构也有助于市场扩张。由于重视永续性和创新，北美微生物脂肪酶市场预计在未来几年将保持上升趋势。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球微生物脂肪酶市场：依来源分类

  • 细菌
  • 菌类
  • 酵母菌
  • 其他来源

第六章全球微生物脂肪酶市场：依形式

  • 液体
  • 粉末
  • 颗粒状
  • 其他格式

第七章全球微生物脂肪酶市场：依纯度

  • 纯脂肪酶
  • 工业级脂肪酶
  • 粗脂肪酶
  • 其他纯度

第八章全球微生物脂肪酶市场：功能性别

  • 脂肪分解
  • 酯交换反应
  • 酯交换反应
  • 酯化反应
  • 其他功能

第九章全球微生物脂肪酶市场：依最终用户分类

  • 食品加工公司
  • 製药公司
  • 化妆品公司
  • 生质燃料製造商
  • 纺织品製造商
  • 其他最终用户

第十章全球微生物脂肪酶市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Novozymes A/S
  • DuPont de Nemours, Inc.
  • DSM Nutritional Products
  • AB Enzymes GmbH
  • Amano Enzyme Inc.
  • Chr. Hansen Holding A/S
  • BASF SE
  • Associated British Foods PLC
  • Enzyme Development Corporation
  • Biocatalysts Limited
  • BioResource International Inc.
  • Novus International Inc.
  • Enzyme Solutions Limited
  • Koninklijke DSM NV
  • Kerry Group
  • Sunson Industry Group
Product Code: SMRC25874

According to Stratistics MRC, the Global Microbial Lipase Market is accounted for $657.27 million in 2023 and is expected to reach $1170.98 million by 2030 growing at a CAGR of 8.6% during the forecast period. Microbial lipase, an enzyme produced by microorganisms like bacteria and fungi, plays a pivotal role in lipid metabolism. It catalyzes the hydrolysis of ester bonds in triglycerides, breaking them down into glycerol and fatty acids. It enhances flavour and texture, and facilitates fat digestion. Its stability across a broad pH and temperature range makes it valuable in industrial processes.

Market Dynamics:

Driver:

Increased awareness about enzyme-based solutions

Enzyme-based solutions, particularly microbial lipases, offer sustainable and eco-friendly alternatives for processes like food production, biofuel manufacturing, and pharmaceuticals. As industries seek more efficient and environmentally friendly solutions, the demand for microbial lipases increases. Their ability to catalyze specific reactions with high specificity and efficiency, coupled with advancements in enzyme engineering and production technologies, further solidifies their position as essential biocatalysts, driving market expansion.

Restraint:

Limited stability and shelf-life

Limited stability and shelf-life in microbial lipases stem from factors such as enzyme denaturation, proteolysis, and aggregation, which can occur during storage or under unfavourable conditions. These limitations hinder their efficacy and suitability for various industrial applications, affecting product quality and performance. Consequently, industries may seek alternative enzyme sources or synthetic substitutes with longer shelf-life and greater stability, reducing reliance on microbial lipases.

Opportunity:

Expanding biotechnology sector

Microbial lipases play crucial roles in biotechnology applications such as biofuel production, pharmaceutical synthesis, and detergent manufacturing. As biotechnology continues to advance, the demand for microbial lipases is expected to rise further, driven by their versatility, efficiency, and eco-friendly nature. This trend fosters innovation in microbial lipase development, enhancing their performance and widening their application scope, thereby fueling market expansion within the biotechnology sector.

Threat:

Technical challenges

Technical challenges in microbial lipase include formulation optimization, process condition fine-tuning, and substrate compatibility. Ensuring optimal enzyme stability and activity across varied industrial conditions poses difficulties. Moreover, achieving cost-effective production methods without compromising quality remains a challenge. These technical hurdles hinder widespread adoption and application of microbial lipases, impacting market growth.

Covid-19 Impact

The covid-19 pandemic has had a mixed impact on the microbial lipase market. While the increased demand for processed foods and detergents has driven up the need for microbial lipases in certain sectors, disruptions in the supply chain, workforce shortages, and economic uncertainties have posed challenges for market players. Additionally, the temporary closure of industries and reduced consumer spending has dampened market growth. However, the market has shown resilience, with rapid adaptation to remote work, increased focus on hygiene products, and accelerated research in biotechnology driving recovery and future growth prospects.

The bacteria segment is expected to be the largest during the forecast period

The bacteria segment is estimated to have a lucrative growth. Microbial lipases, enzymes produced by bacteria, play vital roles in various industrial applications. Derived from diverse bacterial strains, these lipases exhibit remarkable substrate specificity and stability under different conditions, making them invaluable in biotechnology, food processing, and pharmaceuticals. They catalyze the hydrolysis of ester bonds in lipids, facilitating processes like cheese ripening, detergent formulation, and biodiesel production.

The pharmaceutical companies segment is expected to have the highest CAGR during the forecast period

The pharmaceutical companies segment is anticipated to witness the highest CAGR growth during the forecast period. Microbial lipase, an enzyme produced by microorganisms like bacteria and fungi, finds crucial applications in pharmaceutical companies. Its role in drug formulation involves aiding in the synthesis of pharmaceutical compounds, enhancing drug absorption, and improving drug stability. They are essential for the production of enantiomerically pure drugs, thereby ensuring efficacy and minimizing side effects.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period. Rapid industrialization, expanding food and beverage sectors, and increasing demand for enzyme-based products are fueling market expansion. Additionally, rising disposable incomes and changing dietary preferences towards healthier and convenience foods are boosting the demand for microbial lipases in the region. Moreover, favourable government initiatives supporting biotechnology research and development are further propelling market growth.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period. The region's advanced food and beverage industry, coupled with a growing demand for enzyme-based solutions, is a primary driver. Furthermore, technological advancements, robust research and development activities, and a supportive regulatory framework are contributing to market expansion. With a focus on sustainability and innovation, the North American microbial lipase market is expected to continue its upward trajectory in the coming years.

Key players in the market

Some of the key players profiled in the Microbial Lipase Market include Novozymes A/S, DuPont de Nemours, Inc., DSM Nutritional Products, AB Enzymes GmbH, Amano Enzyme Inc., Chr. Hansen Holding A/S, BASF SE, Associated British Foods PLC, Enzyme Development Corporation, Biocatalysts Limited, BioResource International Inc., Novus International Inc., Enzyme Solutions Limited, Koninklijke DSM N.V., Kerry Group and Sunson Industry Group.

Key Developments:

In October 2023, BASF strengthens its enzyme technology for detergents and cleaners with the launch of a new enzymes' generation from its Lavergy(R) portfolio. With the latest expansion of its enzyme portfolio, BASF is raising the bar as an innovation leader and provider of key ingredients for the home care and I&I industry.

In May 2020, Biocatalysts Ltd launched new enzyme Lipomod(R) 767P, it is non-genetically modified microbial lipase preparation suitable for both the hydrolysis and esterification of oils and fats. Its broad spectrum pH profile means it can be used in applications across a wide range of substrate types. This product is an addition to Biocatalyst's extensive range of microbial enzymes, which have been developed to meet the growing demand for clean label products.

Sources Covered:

  • Bacteria
  • Fungi
  • Yeast
  • Other Sources

Forms Covered:

  • Liquid
  • Powder
  • Granular
  • Other Forms

Purities Covered:

  • Pure Lipase
  • Technical Grade Lipase
  • Crude Lipase
  • Other Purities

Functionalities Covered:

  • Lipolysis
  • Transesterification
  • Interesterification
  • Esterification
  • Other Functionalities

End Users Covered:

  • Food Processing Companies
  • Pharmaceutical Companies
  • Cosmetic Companies
  • Biofuel Manufacturers
  • Textile Manufacturers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Microbial Lipase Market, By Source

  • 5.1 Introduction
  • 5.2 Bacteria
  • 5.3 Fungi
  • 5.4 Yeast
  • 5.5 Other Sources

6 Global Microbial Lipase Market, By Form

  • 6.1 Introduction
  • 6.2 Liquid
  • 6.3 Powder
  • 6.4 Granular
  • 6.5 Other Forms

7 Global Microbial Lipase Market, By Purity

  • 7.1 Introduction
  • 7.2 Pure Lipase
  • 7.3 Technical Grade Lipase
  • 7.4 Crude Lipase
  • 7.5 Other Purities

8 Global Microbial Lipase Market, By Functionality

  • 8.1 Introduction
  • 8.2 Lipolysis
  • 8.3 Transesterification
  • 8.4 Interesterification
  • 8.5 Esterification
  • 8.6 Other Functionalities

9 Global Microbial Lipase Market, By End User

  • 9.1 Introduction
  • 9.2 Food Processing Companies
  • 9.3 Pharmaceutical Companies
  • 9.4 Cosmetic Companies
  • 9.5 Biofuel Manufacturers
  • 9.6 Textile Manufacturers
  • 9.7 Other End Users

10 Global Microbial Lipase Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Novozymes A/S
  • 12.2 DuPont de Nemours, Inc.
  • 12.3 DSM Nutritional Products
  • 12.4 AB Enzymes GmbH
  • 12.5 Amano Enzyme Inc.
  • 12.6 Chr. Hansen Holding A/S
  • 12.7 BASF SE
  • 12.8 Associated British Foods PLC
  • 12.9 Enzyme Development Corporation
  • 12.10 Biocatalysts Limited
  • 12.11 BioResource International Inc.
  • 12.12 Novus International Inc.
  • 12.13 Enzyme Solutions Limited
  • 12.14 Koninklijke DSM N.V.
  • 12.15 Kerry Group
  • 12.16 Sunson Industry Group

List of Tables

  • Table 1 Global Microbial Lipase Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Microbial Lipase Market Outlook, By Source (2021-2030) ($MN)
  • Table 3 Global Microbial Lipase Market Outlook, By Bacteria (2021-2030) ($MN)
  • Table 4 Global Microbial Lipase Market Outlook, By Fungi (2021-2030) ($MN)
  • Table 5 Global Microbial Lipase Market Outlook, By Yeast (2021-2030) ($MN)
  • Table 6 Global Microbial Lipase Market Outlook, By Other Sources (2021-2030) ($MN)
  • Table 7 Global Microbial Lipase Market Outlook, By Form (2021-2030) ($MN)
  • Table 8 Global Microbial Lipase Market Outlook, By Liquid (2021-2030) ($MN)
  • Table 9 Global Microbial Lipase Market Outlook, By Powder (2021-2030) ($MN)
  • Table 10 Global Microbial Lipase Market Outlook, By Granular (2021-2030) ($MN)
  • Table 11 Global Microbial Lipase Market Outlook, By Other Forms (2021-2030) ($MN)
  • Table 12 Global Microbial Lipase Market Outlook, By Purity (2021-2030) ($MN)
  • Table 13 Global Microbial Lipase Market Outlook, By Pure Lipase (2021-2030) ($MN)
  • Table 14 Global Microbial Lipase Market Outlook, By Technical Grade Lipase (2021-2030) ($MN)
  • Table 15 Global Microbial Lipase Market Outlook, By Crude Lipase (2021-2030) ($MN)
  • Table 16 Global Microbial Lipase Market Outlook, By Other Purities (2021-2030) ($MN)
  • Table 17 Global Microbial Lipase Market Outlook, By Functionality (2021-2030) ($MN)
  • Table 18 Global Microbial Lipase Market Outlook, By Lipolysis (2021-2030) ($MN)
  • Table 19 Global Microbial Lipase Market Outlook, By Transesterification (2021-2030) ($MN)
  • Table 20 Global Microbial Lipase Market Outlook, By Interesterification (2021-2030) ($MN)
  • Table 21 Global Microbial Lipase Market Outlook, By Esterification (2021-2030) ($MN)
  • Table 22 Global Microbial Lipase Market Outlook, By Other Functionalities (2021-2030) ($MN)
  • Table 23 Global Microbial Lipase Market Outlook, By End User (2021-2030) ($MN)
  • Table 24 Global Microbial Lipase Market Outlook, By Food Processing Companies (2021-2030) ($MN)
  • Table 25 Global Microbial Lipase Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 26 Global Microbial Lipase Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
  • Table 27 Global Microbial Lipase Market Outlook, By Biofuel Manufacturers (2021-2030) ($MN)
  • Table 28 Global Microbial Lipase Market Outlook, By Textile Manufacturers (2021-2030) ($MN)
  • Table 29 Global Microbial Lipase Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.